Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Adequacy of core needle biopsy specimens and fine-needle aspirates for molecular testing of lung adenocarcinomas.

Schneider F, Smith MA, Lane MC, Pantanowitz L, Dacic S, Ohori NP.

Am J Clin Pathol. 2015 Feb;143(2):193-200; quiz 306. doi: 10.1309/AJCPMY8UI7WSFSYY.

PMID:
25596245
2.

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.

Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, Gooding WE, Hodak SP, LeBeau SO, Ohori NP, Seethala RR, Tublin ME, Yip L, Nikiforova MN.

Cancer. 2014 Dec 1;120(23):3627-34. doi: 10.1002/cncr.29038. Epub 2014 Sep 10.

PMID:
25209362
3.

Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.

Radkay LA, Chiosea SI, Seethala RR, Hodak SP, LeBeau SO, Yip L, McCoy KL, Carty SE, Schoedel KE, Nikiforova MN, Nikiforov YE, Ohori NP.

Cancer Cytopathol. 2014 Dec;122(12):873-82. doi: 10.1002/cncy.21474. Epub 2014 Aug 12.

PMID:
25132659
4.

Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.

Singhi AD, Nikiforova MN, Fasanella KE, McGrath KM, Pai RK, Ohori NP, Bartholow TL, Brand RE, Chennat JS, Lu X, Papachristou GI, Slivka A, Zeh HJ, Zureikat AH, Lee KK, Tsung A, Mantha GS, Khalid A.

Clin Cancer Res. 2014 Aug 15;20(16):4381-9. doi: 10.1158/1078-0432.CCR-14-0513. Epub 2014 Jun 17.

PMID:
24938521
5.

A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy.

Yip L, Wharry LI, Armstrong MJ, Silbermann A, McCoy KL, Stang MT, Ohori NP, LeBeau SO, Coyne C, Nikiforova MN, Bauman JE, Johnson JT, Tublin ME, Hodak SP, Nikiforov YE, Carty SE.

Ann Surg. 2014 Jul;260(1):163-8. doi: 10.1097/SLA.0000000000000215.

PMID:
24901361
6.

PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma.

Armstrong MJ, Yang H, Yip L, Ohori NP, McCoy KL, Stang MT, Hodak SP, Nikiforova MN, Carty SE, Nikiforov YE.

Thyroid. 2014 Sep;24(9):1369-74. doi: 10.1089/thy.2014.0067. Epub 2014 Jul 16.

PMID:
24798894
7.

Thyroid nodules (≥4 cm): can ultrasound and cytology reliably exclude cancer?

Wharry LI, McCoy KL, Stang MT, Armstrong MJ, LeBeau SO, Tublin ME, Sholosh B, Silbermann A, Ohori NP, Nikiforov YE, Hodak SP, Carty SE, Yip L.

World J Surg. 2014 Mar;38(3):614-21. doi: 10.1007/s00268-013-2261-9.

PMID:
24081539
8.

Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology.

Mehta RS, Carty SE, Ohori NP, Hodak SP, Coyne C, LeBeau SO, Tublin ME, Stang MT, Johnson JT, McCoy KL, Nikiforova MN, Nikiforov YE, Yip L.

Surgery. 2013 Oct;154(4):730-6; discussion 736-8. doi: 10.1016/j.surg.2013.05.015.

PMID:
24074409
9.

From headache to heartache: ergotamine-induced aortic and mitral valvulopathy.

Patel SM, Ohori NP, Badhwar V, Cavalcante JL.

J Am Coll Cardiol. 2013 Dec 3;62(22):2144. doi: 10.1016/j.jacc.2013.06.065. Epub 2013 Sep 22. No abstract available.

10.

Correlation of ultrasound findings with the Bethesda cytopathology classification for thyroid nodule fine-needle aspiration: a primer for radiologists.

Heller MT, Gilbert C, Ohori NP, Tublin ME.

AJR Am J Roentgenol. 2013 Sep;201(3):W487-94. doi: 10.2214/AJR.12.9071. Review.

PMID:
23971481
11.

"Colloid-rich" follicular neoplasm/suspicious for follicular neoplasm thyroid fine-needle aspiration specimens: cytologic, histologic, and molecular basis for considering an alternate view.

Ohori NP, Wolfe J, Hodak SP, LeBeau SO, Yip L, Carty SE, Duvvuri U, Schoedel KE, Nikiforova MN, Nikiforov YE.

Cancer Cytopathol. 2013 Dec;121(12):718-28. doi: 10.1002/cncy.21333. Epub 2013 Jul 23. Erratum in: Cancer Cytopathol. 2014 Dec;122(12):921.

PMID:
23881852
12.

Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.

Nikiforova MN, Khalid A, Fasanella KE, McGrath KM, Brand RE, Chennat JS, Slivka A, Zeh HJ, Zureikat AH, Krasinskas AM, Ohori NP, Schoedel KE, Navina S, Mantha GS, Pai RK, Singhi AD.

Mod Pathol. 2013 Nov;26(11):1478-87. doi: 10.1038/modpathol.2013.91. Epub 2013 Jun 7.

13.

RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers.

Gupta N, Dasyam AK, Carty SE, Nikiforova MN, Ohori NP, Armstrong M, Yip L, LeBeau SO, McCoy KL, Coyne C, Stang MT, Johnson J, Ferris RL, Seethala R, Nikiforov YE, Hodak SP.

J Clin Endocrinol Metab. 2013 May;98(5):E914-22. doi: 10.1210/jc.2012-3396. Epub 2013 Mar 28.

PMID:
23539734
14.

BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.

Ohori NP, Singhal R, Nikiforova MN, Yip L, Schoedel KE, Coyne C, McCoy KL, LeBeau SO, Hodak SP, Carty SE, Nikiforov YE.

Cancer Cytopathol. 2013 Apr;121(4):197-205. doi: 10.1002/cncy.21229. Epub 2012 Aug 7.

PMID:
22887810
15.

Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer.

McCoy KL, Carty SE, Armstrong MJ, Seethala RR, Ohori NP, Kabaker AS, Stang MT, Hodak SP, Nikiforov YE, Yip L.

J Am Coll Surg. 2012 Oct;215(4):546-54. doi: 10.1016/j.jamcollsurg.2012.05.027. Epub 2012 Jul 4.

PMID:
22766226
16.

Orbital metastasis as the initial presentation of invasive lobular carcinoma of breast.

Tomizawa Y, Ocque R, Ohori NP.

Intern Med. 2012;51(12):1635-8. Epub 2012 Jun 15.

18.

EUS-FNA mutational analysis in differentiating autoimmune pancreatitis and pancreatic cancer.

Khalid A, Dewitt J, Ohori NP, Chen JH, Fasanella KE, Sanders M, McGrath KM, Nikiforova M.

Pancreatology. 2011;11(5):482-6. doi: 10.1159/000331505. Epub 2011 Oct 11.

PMID:
21997479
19.

Selective screening for nongynecologic cytology specimens: modifying the screening process for improved efficiency and practice.

Marks-Jones DA, Sutkowski BA, Schoedel KE, Ohori NP.

Diagn Cytopathol. 2011 Oct;39(10):717-22. doi: 10.1002/dc.21449. Epub 2010 Nov 2.

PMID:
21919214
20.

Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples.

Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN.

J Clin Endocrinol Metab. 2011 Nov;96(11):3390-7. doi: 10.1210/jc.2011-1469. Epub 2011 Aug 31.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk